American Society of Gene & Cell Therapy--13th Annual Meeting.
The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).
Romano
Gaetano
G
Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, BioLife Science Building, Suite 456, 1900 North 12th Street, Philadelphia, PA 19122, USA. gromano@temple.edu
D000256:Adenoviridae / Q000235:genetics / Q000378:metabolism; D000818:Animals; D017690:Cell Transplantation / Q000009:adverse effects / Q000639:trends; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods / Q000639:trends; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects
D015507:Drugs, Investigational